Pharmesis International narrows 3Q losses by 29% to $40,600

SINGAPORE (Nov 9): Pharmesis International reported 3Q17 losses narrowed by 29% to RMB 198,000 ($40,600) compared to RMB 279,000 in 3Q16.

Revenue for the period increased 4.4% to RMB 17.3 million from RMB 16.6 million a year ago, mainly due to higher revenue from the group’s non-prescribed drugs/distribution segment which increased by RMB 1.1 million.